Felodipine Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 2.5 mg, 5 mg, 10 mg
Reference Brands: Plendil (USA/ EU), Felodur (EU), Renedil (EU/UK)
Category:
Heart Disorder
Felodipine is a long-acting calcium channel blocker used to treat high blood pressure and angina pectoris. It works by relaxing the blood vessels, allowing easier blood flow and reducing the heart’s workload. Felodipine is available as extended-release tablets in strengths of 2.5 mg, 5 mg, and 10 mg under brand names such as Plendil, Felodur, Renedil, and Modip. It is designed for once-daily dosing to maintain consistent blood pressure control throughout the day.
Felodipine is available in Tablets
and strengths such as 2.5 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Felodipine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Felodipine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing